{
Madrigal Pharmaceuticals Inc.

Companies

}
001122334455554433221100
001122334455554433221100

madrigal pharmaceuticals shows long-term growth potential with undervalued shares

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is focused on developing innovative treatments for non-alcoholic steatohepatitis (NASH). Its lead candidate, resmetirom, is a once-daily oral medication that acts as a liver-directed thyroid hormone receptor-β agonist, addressing the underlying causes of NASH. The company's clinical development includes several key programs: MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
MarketScreener
Madrigal Pharmaceuticals Inc. USA
Healthcare & Medicine, Market Report
18:37 27.02.2025

ubs maintains buy rating on madrigal pharmaceuticals with target price of 441

UBS has reaffirmed its Buy rating on Madrigal Pharmaceuticals, setting a price target of $441, reflecting confidence in the company's potential in treating metabolic-associated steatohepatitis (MASH). Following strong fourth-quarter results, with revenues of $180 million and a gross margin of 96.54%, analysts remain optimistic about Madrigal's future, particularly with promising data from the Phase 3 MAESTRO-NAFLD-1 trial. The company holds a robust financial position, with cash and marketable securities totaling $931.3 million, and anticipates a potential European launch of its drug Rezdiffra in 2025, pending regulatory approval.
Investing.com
United States Dollar Madrigal Pharmaceuticals Inc. JMP Securities LLC USA Eliana Merle
Finance & Economy, Market Report
17:17 27.02.2025
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Global Trade Developments Finance Mergers & Acquisitions Global Financial Events Banking Regulations Startups & Entrepreneurship Retail and Consumer Goods Industry Mergers & Acquisitions CEO Changes Market Analysis and Predictions Inflation and Monetary Impact Government Policies Government Economic Policies Commodities GDP Growth & Recession Forecasts Central Bank Actions Hedge Funds & Private Equity Domestic Politics
Countries:
USA GBR CHE CHN IND JPN CAN ESP FRA DEU ITA MEX SGP ARE BRA VNM AUT LIE TWN BEL
Companies:
Barclays PLC JPMorgan Chase & Co. Apple Inc. Tesla, Inc. Banco Santander, S.A. Berkshire Hathaway Inc. The Goldman Sachs Group, Inc. Commerzbank AG NVIDIA Corporation Morgan Stanley Amazon.com, Inc. Lloyds Banking Group plc Bank of America Corporation Wells Fargo & Company SpaceXCoin USD Deutsche Bank Money Market PP Citigroup Inc. Royal Bank of Canada Microsoft Corporation UBS Group AG
Currencies:
United States Dollar Euro British Pound Sterling Swiss Franc Indian Rupee Japanese Yen Chinese Yuan New Taiwan Dollar United Arab Emirates Dirham South Korean Won Vietnamese Đồng Canadian Dollar Danish Krone Indonesian Rupiah Russian Ruble Singapore Dollar Chilean Peso Egyptian Pound Cambodian Riel
People:
Donald Trump Elon Musk Warren Buffett Troy L Rohrbaugh Alex Kramm JD Vance Robin Leopold Pierin Vincenz Carsten Fritsch Ana Botina Jeff Bezos Stacey Friedman Karoline Leavitt Stefan Rauti Manav Patnaik Jesús Aguado Inti Landauro Mark Zuckerberg Ana Patricia Botin Ashwani Verma

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.